Lamed GmbH, founded in 1989, is an established and reliable partner in the healthcare market with over 30 years of experience. The company specializes in the distribution and market access of innovative vascular and cardiovascular products and serves a broad network of over 1,000 hospitals in Germany, the largest market for interventional cardiology in Europe[1][2][3], with its exclusive product range.
The core business of Lamed consists of the distribution of differentiated products from international suppliers, which are used specifically in the field of interventional cardiology, vascular surgery and structural heart diseases. Lamed acts as a market access platform (GPO) and, thanks to long-standing and in-depth relationships with the healthcare system, enables optimal care for clinics with high-quality medical devices and technologies. The close cooperation with well-known manufacturers and its strong presence in the German healthcare market make Lamed a key player in this sector[1][2].
The corporate mission of Lamed focuses on high-quality and sustainable medical care by providing innovative products and efficient solutions for medical facilities. Under the leadership of an experienced management team that brings over 30 years of expertise, the company focuses on trust, reliability and long-term partnerships in the healthcare environment[3][4].
In terms of sustainability goals, Lamed pursues a conscious use of resources and a sense of social responsibility, which is also reflected in the corporate culture. Although concrete sustainability initiatives are not prominently displayed on the website, evaluations and internal structures show approaches to promoting a responsible approach to environmental and social aspects. This includes aspects such as the careful handling of medical products and the promotion of an inclusive working environment[5].
In June 2023, Lamed was acquired by Translumina, a global manufacturer of interventional cardiovascular medical devices with production sites in Germany and India. This strategic partnership underscores the importance of Lamed as a central platform for market access to vascular and cardiovascular products in Germany. Translumina intends to use Lamed's established infrastructure to expand its product portfolio and introduce innovative technologies to the German market, which will further strengthen future growth and market presence[1][2].
In summary, Lamed GmbH is an experienced company focused on sustainable medical care, which plays a central role in the German healthcare market with its comprehensive network and exclusive product offerings and continues to expand and drive innovation through its integration into the global Translumina Group.
